Back to Search
Start Over
Experiences of community pharmacists administering COVID-19 vaccinations: A qualitative study
- Source :
- Canadian Pharmacists Journal; January 2023, Vol. 156 Issue: Supplement 1 p7S-17S, 11p
- Publication Year :
- 2023
-
Abstract
- Background: Throughout the COVID-19 pandemic, community pharmacists have played an important role in the provision of patient care, including the delivery of COVID-19 vaccines. The additional workload and related demands arising from these extended services might affect worklife burnout. This qualitative study explored the experiences of Canadian community pharmacists in providing COVID-19 vaccines during the COVID-19 pandemic.Methods: Eighteen community pharmacists across 10 provinces were asked about vaccination processes and perceptions about their role in separate, virtual semistructured interviews. Interviews were transcribed verbatim and analyzed using a deductive approach using the Areas of Worklife Burnout framework, with pharmacists’ self-reported descriptions of their activities summarized using the Association of Faculties of Pharmacy of Canada’s (AFPC) professional competencies framework.Results: Participants identified aspects of their role that were rewarding and challenging. Some challenges included lack of control, increased workload, inadequate communication, unfair treatment and conflicting values. They described being able to meet challenges and demonstrating resiliency via adaptability, developing communities and valuing their contribution to ending the COVID-19 pandemic. Self-identified AFPC competencies contributing to their ability to manage their worklife included care-provider, professional, leader-manager, collaborator and scholar.Conclusion: Pharmacists accepted their additional responsibility of managing COVID-19 vaccines during the COVID-19 pandemic. However, they expressed some challenges with this role. To ensure sustainability of these services, prioritizing adequate resources, work processes and efficient communication with all relevant stakeholder groups, including public health, government and corporate leaders, is recommended for the future. Can Pharm J (Ott)2023;156(Suppl):xx-xx.
Details
- Language :
- English
- ISSN :
- 17151635 and 1913701X
- Volume :
- 156
- Issue :
- Supplement 1
- Database :
- Supplemental Index
- Journal :
- Canadian Pharmacists Journal
- Publication Type :
- Periodical
- Accession number :
- ejs62138327
- Full Text :
- https://doi.org/10.1177/17151635221136552